Skip to main content
SpringerLink
Log in

Rationale and Design for the SARIS Trial; Effect of Statin on Atherosclerosis and Vascular Remodeling Assessed with Intravascular Sonography

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose. The SARIS study (effect of Statin on Atherosclerosis and vascular Remodeling assessed with Intravascular Sonography) is a prospective randomized multicenter trial designed to assess both morphological and functional cardiovascular effects of atorvastatin.

Methods. Participating centers will include 50 patients with normal to mildly elevated cholesterol levels eligible for balloon angioplasty and/or stent placement of the common iliac artery. Patients will be randomized to 1-year treatment with either low-dose (10 mg) or high-dose (80 mg) atorvastatin. The morphological effects of atorvastatin will be studied using intravascular ultrasound (IVUS); the effect of atorvastatin on both plaque volume and vascular remodeling seen at 1-year follow-up will be investigated. The functional cardiovascular effects of atorvastatin will be studied using dobutamine stress echocardiography (DSE); the effect of atorvastatin on myocardial coronary flow reserve at 6-months and 1-year follow-up will be investigated. The aims of the present study are noteworthy in respect that (1) IVUS is the only available technique to sensitively measure the effect of atorvastatin on both intimal hyperplasia and vascular remodeling, and (2) DSE is a non-invasive test to objectively quantify the effect of atorvastatin on the functionality of the coronary artery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.

  2. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.

    PubMed  Google Scholar 

  3. Jukema JW, Bruschke AV, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91: 2528-2540.

    PubMed  Google Scholar 

  4. de Groot E, Jukema JW, Montauban van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings:Areport of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998; 31: 1561-1567.

    PubMed  Google Scholar 

  5. Di Mario C, Gil R, Camenzind E, et al. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol 1995; 75: 772-777.

    PubMed  Google Scholar 

  6. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 1996; 94: 35-43.

    PubMed  Google Scholar 

  7. Luo H, Nishioka T, Eigler NL, et al. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. Arterioscler Thromb Vasc Biol 1996; 16: 1393-1398.

    PubMed  Google Scholar 

  8. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997; 96: 475-483.

    PubMed  Google Scholar 

  9. van Lankeren W, Gussenhoven EJ, Honkoop J, et al. Plaque area increase and vascular remodeling contribute to lumen area change after percutaneous transluminal angioplasty of the femoropopliteal artery: An intravascular ultrasound study. J Vasc Surg 1999; 29: 430-441.

    PubMed  Google Scholar 

  10. Hagenaars T, Gussenhoven EJ, Kranendonk SE, et al. Progression of atherosclerosis at one-year follow-up seen with Design of the SARIS Trial volumetric intravascular ultrasound in femoropopliteal arteries. Am J Cardiol 2000; 85: 226-231.

    PubMed  Google Scholar 

  11. Aengevaeren WR. Beyond lipids-the role of the endothelium in coronary artery disease. Atherosclerosis 1999; 147(Suppl 1): S11-S16.

    PubMed  Google Scholar 

  12. Jarvisalo MJ, Toikka JO, Vasankari T, et al. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis 1999; 147: 237-242.

    PubMed  Google Scholar 

  13. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endotheliumdependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519-2524.

    PubMed  Google Scholar 

  14. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.

    PubMed  Google Scholar 

  15. Vita JA, Yeung AC, Winniford M, et al. Effect of cholesterollowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation 2000; 102: 846-851.

    PubMed  Google Scholar 

  16. Isaaz K, Munoz del Romeral L, Lee E, Schiller NB. Quantitation of the motion of the cardiac base in normal subjects by Doppler echocardiography. J AmSoc Echocardiogr 1993; 6: 166-176.

    Google Scholar 

  17. Sutherland GR, Stewart MJ, Groundstroem KW, et al. Color Doppler myocardial imaging: A new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994; 7: 441-458.

    PubMed  Google Scholar 

  18. Gorcsan J, III, Deswal A, Mankad S, et al. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. Am J Cardiol 1998; 81: 615-623.

    PubMed  Google Scholar 

  19. Hagenaars T, Gussenhoven EJ, van Essen JA, Seelen J, Honkoop J, van der Lugt A. Reproducibility of volumetric quantification in intravascular ultrasound images. Ultrasound Med Biol 2000; 26: 367-374.

    PubMed  Google Scholar 

  20. Takagi T, Yoshida K, Akasaka T, Hozumi T, Morioka S, Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 1997; 79: 1673-1676.

    PubMed  Google Scholar 

  21. Hamasaki S, Higano ST, Suwaidi JA, et al. Cholesterollowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol 2000; 20: 737-743.

    PubMed  Google Scholar 

  22. Hagenaars T, Gussenhoven EJ, van Sambeek MR, Jukema JW, Kranendonk SE, Bom N. Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction. Am J Cardiol 2000; 86: 774-776.

    PubMed  Google Scholar 

  23. Yokoyama I, Momomura S, Ohtake T, et al. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipidlowering therapy. Circulation 1999; 100: 117-122.

    PubMed  Google Scholar 

  24. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999; 99: 2871-2875.

    PubMed  Google Scholar 

  25. Rambaldi R, Poldermans D, Bax JJ, et al. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/ fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction. Am J Cardiol 1999; 84: 130-134.

    PubMed  Google Scholar 

  26. Rambaldi R, Poldermans D, Bax JJ, et al. Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 2000; 21: 1091-1098.

    PubMed  Google Scholar 

  27. von Bibra H, Tuchnitz A, Klein A, Schneider-Eicke J, Schomig A, Schwaiger M. Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: A comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol 2000; 36: 444-452.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Experimental Echocardiography, Utrecht, The Netherlands

    Tjebbe Hagenaars & Elma J. Gussenhoven

  2. Departments of Interuniversity Cardiology Institute, Utrecht, The Netherlands

    Tjebbe Hagenaars & Elma J. Gussenhoven

  3. Departments of Internal Medicine, Rotterdam, The Netherlands

    Don Poldermans

  4. Departments of Vascular Surgery, Rotterdam, The Netherlands

    Don Poldermans & Hero van Urk

  5. Departments of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands

    Aad van der Lugt

Authors
  1. Tjebbe Hagenaars
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elma J. Gussenhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Don Poldermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hero van Urk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aad van der Lugt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hagenaars, T., Gussenhoven, E.J., Poldermans, D. et al. Rationale and Design for the SARIS Trial; Effect of Statin on Atherosclerosis and Vascular Remodeling Assessed with Intravascular Sonography. Cardiovasc Drugs Ther 15, 339–343 (2001). https://doi.org/10.1023/A:1012762715944

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012762715944

Search

Navigation